Aranami Toshimasa, Yamamura Takashi
Department of Immunology, National Institute of Neuroscience, National Center for Neurology and Psychiatry.
Nihon Rinsho. 2013 May;71(5):850-4.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is considered to be a demyelinating autoimmune disorder in the peripheral nervous system. Concerning cellular immune response, activity of IFN-gamma producing Th1 and IL-17 producing Th17 cells might be accelerated in patients with CIDP, while regulatory function of CD4+ CD25(high) Foxp3+ regulatory T cells might be diminished. Humoral immune responses against several myelin components such as myelin protein zero and gangliosides such as GM1 might be also induced in a part of patients with CIDP. Besides, growing body of evidences suggest that immune response against several molecules expressed in the noncompact myelin might be involved in the pathogenesis of CIDP.
慢性炎症性脱髓鞘性多发性神经病(CIDP)被认为是一种外周神经系统的脱髓鞘自身免疫性疾病。关于细胞免疫反应,CIDP患者中产生干扰素-γ的Th1细胞和产生白细胞介素-17的Th17细胞的活性可能会加速,而CD4+CD25(高)Foxp3+调节性T细胞的调节功能可能会减弱。一部分CIDP患者也可能诱导针对几种髓鞘成分(如髓鞘蛋白零)和神经节苷脂(如GM1)的体液免疫反应。此外,越来越多的证据表明,针对非致密髓鞘中表达的几种分子的免疫反应可能参与了CIDP的发病机制。